Effect of a pharmaceutical intervention on the level of control of the asthmatic patient
Study identifier:NIS-RES-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Effect of a pharmaceutical intervention on the level of control of the asthmatic patient
Medical condition
asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
384
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Apr 2010
Primary Completion Date: 01 Jul 2011
Study Completion Date: 01 Jul 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 1. Pilot Study: 60 patients (all in the intervention group) 30 patients with intervention A and 30 patients with B intervention) | Other: 1 In the pilot study the objective is to compare 2 different pharmaceutical interventions (A and B) and to assess which one improves disease control, patient adherence and patient knowledge of the medication. |
| 2 Main Study: 600 patients (30 pharmacies control group and 30 pharmacies intervention group, 10 patients per pharmacy) | Other: 2 The best intervention used in the pilot study will be chosen and included in the main study. |
